Live Quote · NASDAQVSTMHealthcare· Biotechnology

Verastem, Inc.

$4.50 9.76%(+$0.40)
TickerSpark Score
60/100
Mixed
60
Valuation
40
Profitability
95
Growth
76
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VSTM research report →

52-Week Range14% of range
Low
$3.43
Current
$4.50
High
$11.25
Company Overviewwww.verastem.com

About the company

Verastem, Inc. is an emerging biopharmaceutical company dedicated to the creation and commercialization of innovative therapeutic agents for cancer treatment. A primary asset in its pipeline is VS-6766, a novel dual RAF/MEK inhibitor that operates by a "clamp" mechanism.

CEO
Daniel W. Paterson
IPO
2012
Employees
78
HQ
Needham, MA, US

Price Chart

-7.22% · this period
$10.77$7.11$3.45Jul 02Dec 31Jul 02
Valuation
Market Cap
$311.91M
P/E
-1.80
P/S
6.29
P/B
5.41
EV/EBITDA
-1.21
Div Yield
0.00%
Profitability
Gross Margin
83.75%
Op Margin
-344.56%
Net Margin
-391.16%
ROE
-486.41%
ROIC
-102.15%
Growth & Income
Revenue
$30.91M · 209.14%
Net Income
$-209,471,000 · -60.35%
EPS
$-3.02 · 17.49%
Op Income
$-170,129,000
FCF YoY
-31.21%
Performance & Tape
52W High
$11.25
52W Low
$3.43
50D MA
$4.53
200D MA
$6.77
Beta
0.29
Avg Volume
2.45M

Get TickerSpark's AI analysis on VSTM

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jun 22, 26Paterson Dansell20,871
Jun 22, 26Calkins Danielsell4,032
Jun 22, 26Calkins Danielsell57
May 21, 26BAILEY MICHAEL Pother108,000
May 21, 26BAILEY MICHAEL Pother0
May 21, 26Tollefson Karin Annaother36,000
May 21, 26Stuglik Brian Mother36,000
May 21, 26Rowinsky Eric Kother36,000
May 21, 26ROBERTSON MICHELLEother36,000
May 21, 26Kapur Anilother36,000
Coverage · VSTM

Our VSTM coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on VSTM yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate VSTM report →
Internal Compare

Similar companies

Peers in the same neighborhood.